Informe de análisis del tamaño, la cuota de mercado y las tendencias del mercado de soluciones de análisis de datos clínicos por modo de implementación (local, basado en la nube), por aplicación (soporte para la toma de decisiones clínicas, ensayos clínicos, cumplimiento normativo) y por región (América del Norte, Europa, Asia-Pacífico, Oriente Medio y África, Latinoamérica). Previsiones para el período 2024-2032.

Market dynamics

Factors driving the global market for clinical data analytics solutions:

Increasing volume of clinical data

The exponential growth of clinical data generated by electronic health records (EHRs), medical imaging, genetic sequencing, wearable devices, and other sources requires advanced analytical solutions to manage and extract valuable insights from these massive datasets. The increasing implementation of EHR systems in healthcare organizations has resulted in a huge influx of digitized patient data. According to healthit.gov, by 2021, 96% of non-federal intensive care hospitals in the United States will have implemented a certified EHR, a 10-year increase from 34% in 2011. According to a 2023 study, the use of essential EHRs increased from 6.6% to 81.2%, while comprehensive systems rose from 3.6% to 63.2%.

Furthermore, the widespread use of medical imaging technologies such as MRI, CT, and X-rays produces enormous volumes of digital image data. For example, a single CT scan can generate hundreds of images, contributing to the overall volume of clinical data. Similarly, advances in genomics and genetic testing technology have enabled the collection of vast amounts of genomic data for precision medicine projects and research studies. For instance, the cost of genome sequencing has decreased significantly over time, making it more accessible. In 2023, the cost to sequence a human genome is expected to be around US$600, down from US$10,000 ten years earlier. This is a remarkable achievement, given that the Human Genome Project (HGP) initially cost US$2.7 billion to map the genome in two years.

Además, a medida que aumenta el volumen de datos clínicos, las empresas del sector sanitario deben implementar soluciones analíticas sofisticadas para gestionar, analizar y extraer información valiosa de estos enormes conjuntos de datos. Las soluciones de análisis de datos clínicos utilizan almacenamiento de datos, inteligencia empresarial e inteligencia artificial para extraer información práctica que mejore la atención al paciente, optimice los flujos de trabajo clínicos y potencie los resultados sanitarios.

Restricciones del mercado global de soluciones de análisis de datos clínicos:

Preocupaciones sobre la seguridad y la privacidad de los datos

Las organizaciones sanitarias deben cumplir con una legislación estricta y requisitos de cumplimiento para la privacidad y seguridad de los datos de los pacientes, como HIPAA en Estados Unidos y GDPR en la Unión Europea. La preocupación por las filtraciones de datos, el acceso ilegal y el abuso de la información de los pacientes puede impedir la adopción de soluciones de análisis de datos clínicos, en particular las plataformas basadas en la nube que requieren el intercambio y almacenamiento de datos. Según el Informe de IBM sobre el coste de una filtración de datos de 2023, el coste medio de una filtración de datos a nivel mundial en 2023 fue de 4,45 millones de dólares, un aumento del 15 % con respecto a 2020. Este es el coste más elevado jamás registrado. Según el análisis, el coste medio de una filtración de datos en 2023 será un 2,25 % superior al de 2022, que fue de 4,35 millones de dólares. En mayo de 2023, IBM notificó a HCPF sobre el problema, que resultó en el acceso ilegal a los números de la Seguridad Social, identidades, información médica e información sanitaria de más de 4 millones de beneficiarios.

Además, en 2023, el sector sanitario registró la mayor duración media de las filtraciones de datos, tardando 92 días en ser contenidas, en comparación con los 73 días de otros sectores. El sector sanitario también sufrió el mayor número de filtraciones de datos en 2023, con 725 ataques informáticos que provocaron la pérdida de más de 124 millones de historiales médicos. Estas estadísticas ponen de manifiesto las graves repercusiones financieras y para la reputación que conllevan las filtraciones de datos en el sector sanitario. A medida que las empresas sanitarias utilizan soluciones de análisis de datos clínicos para mejorar la atención al paciente y la eficiencia operativa, resolver las preocupaciones sobre la privacidad y la seguridad de los datos es fundamental para mantener la confianza, el cumplimiento normativo y la adopción eficaz de la analítica.

Oportunidad de mercado global para soluciones de análisis de datos clínicos:

Integración de la inteligencia artificial y el aprendizaje automático

Integrating artificial intelligence (AI) and machine learning (ML) algorithms into clinical data analytics solutions offers opportunities to improve predictive analytics, anomaly detection, and pattern recognition. AI-powered analytics systems can automate data processing, uncover hidden relationships, and provide valuable insights from large clinical datasets, leading to more accurate diagnoses, treatment plans, and disease management.

Furthermore, a study published in JAMA Network Open demonstrated that AI algorithms can improve diagnostic accuracy and patient outcomes in radiology. The study found that an AI system developed by Google Health outperformed radiologists in diagnosing breast cancer from mammograms, reducing false positives and false negatives by 5.7% and 9.4%, respectively. These findings demonstrate how AI-based clinical data analysis systems improve diagnostic accuracy, patient safety, and the quality of healthcare.

Furthermore, a McKinsey & Company analysis indicates that AI applications in the healthcare sector could generate $200 billion in annual value in the United States alone, thanks to advancements in diagnosis and treatment, improvements in operational efficiency, and savings in administrative costs. AI-based clinical data analytics systems have the potential to transform healthcare delivery, enabling more precise, personalized, and proactive care, while reducing healthcare inequalities and improving patient outcomes.

Solicitar personalizaciónpara recibir un informe personalizado.

Segment analysis

The global market for clinical data analysis solutions is segmented based on its implementation and application.

The market is further segmented through deployment in cloud-based areas and on customer premises.

The cloud-based sector dominated the market in 2023, with a 60% revenue market share, and is expected to grow even faster throughout the forecast period. Cloud-based deployments provide clinical data analytics solutions on remote servers located on the internet, which users can access via web browsers or application interfaces. Cloud-based deployments offer scalability, flexibility, and affordability, enabling healthcare organizations to quickly deploy and expand analytics systems without large upfront infrastructure investments. With internet access, it provides seamless access to data and analytics tools from any location or device, enabling collaboration, remote work, and real-time decision-making.

Furthermore, cloud-based systems typically include advanced security protections and data encryption processes to safeguard the confidentiality, integrity, and availability of critical healthcare information. The growth of this segment is due to its scalability advantages for healthcare organizations, enabling them to adapt their analytics infrastructure to evolving data demands.

On-premises deployment involves hosting clinical data analytics tools within the organization's physical infrastructure, including servers and data centers located on the healthcare facility's premises. This on-premises approach gives healthcare organizations greater control over data governance, security, and personalization, as they own and manage the hardware, software, and data resources. However, on-premises deployments typically require larger upfront investments, longer implementation timelines, and ongoing maintenance and support costs. Scaling the infrastructure to accommodate the growing volume of data and constantly evolving analytical needs can also be more labor-intensive than the scalability and agility offered by cloud solutions.

The market for clinical data analysis solutions can be divided into two: on-demand applications in clinical decision support systems, clinical trials, and regulatory compliance.

The clinical trials sector captured the largest market share for clinical data analytics solutions, driven by growing awareness of their benefits in this context. Clinical data analytics solutions are essential for designing, managing, and analyzing clinical trials to evaluate the safety and efficacy of new drugs, medical devices, and therapeutic treatments. These systems enable researchers to collect, standardize, and analyze clinical trial data from diverse sources, including electronic health records, laboratory tests, and patient-reported outcomes. Clinical trials can be conducted more efficiently using sophisticated analytical approaches such as predictive modeling and real-world evidence analysis, resulting in improved patient recruitment, greater protocol adherence, and better trial results.

Furthermore, the growing number of clinical trials, driven by the need for technologically advanced and cost-effective medical treatments, is a significant motivating factor. According to a WHO study published in February 2023, the total number of clinical trials increased from 51,451 in 2017 to 54,954 in 2022.

The clinical decision support (CDS) segment is projected to experience the strongest growth during the forecast period. These systems use clinical data analytics to provide healthcare professionals with relevant information and evidence-based suggestions during patient care. These solutions utilize patient data, medical literature, and best practices to help clinicians diagnose diseases, select appropriate therapies, and improve clinical outcomes. CDS solutions contribute to reducing medical errors, improving the quality of care, and optimizing treatments by combining patient-specific data with clinical guidelines and knowledge resources.

Furthermore, the expansion of this segment is driven by the increasing use of clinical decision support systems (CDS) to personalize recommendations and treatment plans based on each patient's specific profile. Clinical data analytics solutions are fundamental to enhancing CDS, as they provide physicians with patient-specific information and enable targeted and effective therapies. These technologies also incorporate artificial intelligence and machine learning into CDS applications, providing predictive insights for early diagnosis and treatment planning. These factors are expected to further drive the expansion of this segment during the forecast period.

Hablar con un analistapara analizar las oportunidades del mercado.

Regional analysis

The analysis of the global market for clinical data analysis solutions is conducted in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

North America dominates the global market.

North America is the leading player in the global market for clinical data analytics solutions and is projected to grow at a compound annual growth rate (CAGR) of 26.6% during the forecast period. North America dominated the market in 2023, accounting for 43.66% of total revenue, driven by the region's robust healthcare infrastructure and widespread adoption of modern technology. The increasing prevalence of chronic diseases and an aging population are compelling regional healthcare facilities to implement analytical solutions. Furthermore, the presence of major industry players contributes to market growth. According to ClinicalTrials.gov, the United States accounted for 34% of all registered clinical trials in 2022. Reviewing and analyzing data from diverse sources is essential for developing effective population health management plans.

Furthermore, according to the same source, the United States accounted for 37% of all registered clinical trials worldwide. New Medicare requirements from the U.S. government will expose hospitals and physicians to financial penalties if they do not use electronic health records (EHRs). While the United States has long been considered a pioneer in the use of innovative technologies for patient care, physicians and hospitals have had to move quickly to replace paper records with electronic ones. These initiatives are being undertaken to make electronic health records more user-friendly. The implementation of these new regulations will increase regional demand for clinical data analytics solutions.

Europe is projected to experience a compound annual growth rate (CAGR) of 26.9% during the forecast period. Europe is expected to see the largest increase during this time. This expansion is driven by interoperability measures, which are crucial in a region with diverse and often fragmented healthcare systems. The European healthcare sector is adopting AI and machine learning technologies, particularly in radiology and pathology, to rapidly evaluate large datasets. Governments are also investing in digital health infrastructure and promoting clinical data analytics solutions to improve access to healthcare, reduce costs, and enhance patient outcomes.

Furthermore, the demand for medical supplies, equipment, information technology, and support services is constantly expanding. According to forecasts for data management in the UK healthcare sector, the last two years have seen a rapid and significant increase, leading to the construction of numerous new hospitals, COVID-19 testing centers, and healthcare-oriented transport infrastructure.

As a result, a huge amount of unstructured data, such as information on patients, coronavirus survivors, deaths associated with them, vaccines administered, infection rates, and other miscellaneous data, prompted healthcare professionals to use clinical data analysis technologies.

The Asia-Pacific region is projected to be the fastest-growing market. Increased healthcare spending, rapid digital transformation, and growing awareness of the importance of strengthening healthcare infrastructure in countries like China and India are driving market growth. This heightened awareness, the large patient population, and the implementation of advanced technologies all contribute to the region's rapid growth potential.

Furthermore, in India there is a growing interest in reducing healthcare spending and improving patient outcomes. This opens the door to the use of big data in the country's healthcare system, where such information can be analyzed quickly and decisions made based on large volumes of data.

Descubra información regionalpara acceder a datos por país y tendencias regionales.